Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Clinical trial NCT04925479 · RECRUITING
Trial details
- NCT number
- NCT04925479
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-27
- Primary completion
- 2027-09-21
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.